Our ability to identify known pathways associated with Hsp90 and prostate cancer through omics analysis of PDE tissues highlights the capacity for omics identification of novel targets and biomarkers in the face of prostate tumor heterogeneity. The gene discussed is ALDH7A1; the disease is prostate neoplasm.